Krista Davis - 12 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, CHIEF HR OFFICER
Signature
/s/ Krista Davis, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Feb 2026
Net transactions value
-$190,300
Form type
4
Filing time
17 Feb 2026, 16:05:03 UTC
Previous filing
13 Feb 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Krista SVP, CHIEF HR OFFICER C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Krista Davis, by attorney-in-fact Meredith W. Cook 17 Feb 2026 0001946439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $90,506 -1,180 -2.1% $76.70 54,367 12 Feb 2026 Direct F1
transaction ANIP Common Stock Tax liability $99,794 -1,290 -2.4% $77.36 53,077 14 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,264 shares of restricted stock, the grant of which was previously reported on February 18, 2025.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,020 shares of restricted stock, the grant of which was previously reported on February 16, 2024.